Brazil Can Save US$ 600 Million in 5 Years by Copycating Patented AIDS Drugs

    Brazil has the developing world’s most successful AIDS/HIV treatment and prevention program. Its operation is very simple: any HIV-positive Brazilian who cannot afford treatment can obtain the so-called AIDS cocktail drugs from the government free of charge.

    At the moment there are around 160,000 people enrolled in the program. Brazil uses a total of seventeen drugs; ten of them are no longer protected by patents and copycat versions are produced in Brazil at a low cost.


    The other seven are patented and that’s the rub. They are so expensive that just paying for a few of them eats up most of the government’s AIDS/HIV budget.


    Recently, following long, arduous and unfruitful negotiations with pharmaceutical companies for price reductions, Brazil announced it is considering breaking the patents of at least three AIDS drugs, known as Kaletra (Ritonavir/Lopinavir), Efavirenz and Tenofovir.


    The head of the AIDS program, Pedro Chequer, explains that Brazil has the necessary manufacturing know-how and could economize as much as US$ 600 million in five years by producing its own generic versions of the three drugs. “That is money we could invest in our own AIDS research,” he reports.


    Chequer points out that last year Brazil began sharing its AIDS treatment and prevention program, along with its cheap generic drugs, with other countries at no cost to those countries.


    So far the Portuguese-speaking nations of East Timor, Guinea-Bissau, Cabo Verde and São Tomé and Prí­ncipe, along with South American neighbors, Paraguay and Uruguay, are receiving assistance from Brazil which also includes healthcare personnel training programs.


    “We are not doing this for profit. We see AIDS as a question of solidarity and human rights,” declared Chequer.


    Agência Brasil

    Tags:

    • Show Comments (0)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    Sarney in Veja

    Charged with Having Secret Overseas Account Brazil’s Senate Chief Asks for Inquiry

    José Sarney, Brazil's senate president and the nation's former president (1985/1990), said he would ...

    Brazilian Companies Go Looking for Foreign Partners

    The National Confederation of Industries (CNI) is investing in services at its International Business ...

    Waiting for President Godot in Sí£o Paulo, Brazil

    Yesterday Ibope and Datafolha both published their latest polls. According to Ibope, compared to ...

    Short story

      Two friends and a bore   Os dois estavam tomando um cafezinho no ...

    In Brazil Corruption Launders More Money than Drug and Numbers Game Mafias

    Corruption is the chief crime behind money-laundering in Brazil, in the opinion of the ...

    Brazil’s Suzano Papel e Celulose Talks About Growth

    Suzano Bahia Sul Papel e Celulose S.A., one of Latin America’s largest integrated pulp ...

    EU Invests in Program to Export Brazil’s Lesser Known Fruits

    Ricardo Elesbão Alves, a researcher in the EMBRAPA (Brazilian Agricultural Research Company) Tropical Agroindustry ...

    Brazil Surplus Reaches US$ 29 Billion for the Year

    Last week, Brazil exported US$ 2.931 billion and imported US$ 2.193 billion, which resulted ...

    Brazilian Inflation to Be Below 6%, But Above Government’s Target

    Brazil’s Broad Consumer Price Index (IPCA) is expected to end the year at around ...